1. National Institutes of Health; National Heart, Lung, and Blood Institute (NHLBI). Morbidity and Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD: NHLBI; 2012.
2. Xu JQ Murphy SL Kochanek KD Bastian BA . Deaths: final data for 2013. In: National Vital Statistics Reports. Vol. 64. Hyattsville, MD: National Center for Health Statistics; 2016.
3. The future of chronic obstructive pulmonary disease treatment—difficulties of and barriers to drug development
4. Estimating The Cost Of New Drug Development: Is It Really $802 Million?
5. Challenges and current efforts in the development of biomarkers for chronic inflammatory and remodeling conditions of the lungs;Grunig;Biomark Insights.,2016